Case control study to identify risk factors for acute hepatitis C virus infection in Egypt

被引:32
作者
Kandeel, Amr M. [2 ]
Talaat, Maha [1 ]
Afifi, Salma A. [1 ]
El-Sayed, Nasr M. [2 ]
Fadeel, Moustafa A. Abdel [1 ]
Hajjeh, Rana A. [3 ]
Mahoney, Frank J. [4 ]
机构
[1] USN, Med Res Unit NAMRU 3 3, FPO, AE 09835 USA
[2] Minist Hlth & Populat, Prevent & Endem Dis Sect, Cairo, Egypt
[3] Ctr Dis Control & Prevent, Div Bacterial Dis, Atlanta, GA USA
[4] Ctr Dis Control & Prevent, Jakarta, Indonesia
关键词
Acute Hepatitis C; Risk factor; Egypt; TRANSMISSION; EPIDEMIOLOGY; SURVEILLANCE; COLONOSCOPY; CHALLENGES; COMMUNITY; EXPOSURE;
D O I
10.1186/1471-2334-12-294
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Identification of risk factors of acute hepatitis C virus (HCV) infection in Egypt is crucial to develop appropriate prevention strategies. Methods: We conducted a case-control study, June 2007-September 2008, to investigate risk factors for acute HCV infection in Egypt among 86 patients and 287 age and gender matched controls identified in two infectious disease hospitals in Cairo and Alexandria. Case-patients were defined as: any patient with symptoms of acute hepatitis; lab tested positive for HCV antibodies and negative for HBsAg, HBc IgM, HAV IgM; and 7-fold increase in the upper limit of transaminase levels. Controls were selected from patients' visitors with negative viral hepatitis markers. Subjects were interviewed about previous exposures within six months, including community-acquired and health-care associated practices. Results: Case-patients were more likely than controls to have received injection with a reused syringe (OR=23.1, CI 4.7-153), to have been in prison (OR=21.5, CI 2.5-479.6), to have received IV fluids in a hospital (OR=13.8, CI 5.3-37.2), to have been an IV drug user (OR=12.1, CI 4.6-33.1), to have had minimal surgical procedures (OR=9.7, CI 4.2-22.4), to have received IV fluid as an outpatient (OR=8, CI 4-16.2), or to have been admitted to hospital (OR=7.9, CI 4.2-15) within the last 6 months. Multivariate analysis indicated that unsafe health facility practices are the main risk factors associated with transmission of HCV infection in Egypt. Conclusion: In Egypt, focusing acute HCV prevention measures on health-care settings would have a beneficial impact.
引用
收藏
页数:8
相关论文
共 31 条
[1]  
Alter MJ, 2002, J HEPATOL, V36, P593
[2]  
[Anonymous], 2007, CTR DIS CONTR PREV C
[3]  
Argentero PA, 2007, MED LAV, V98, P145
[4]  
Bécheur H, 2000, GASTROEN CLIN BIOL, V24, P906
[5]   Patient-to-patient transmission of hepatitis C virus during colonoscopy [J].
Bronowicki, JP ;
Venard, V ;
Botte, C ;
Monhoven, N ;
Gastin, I ;
Chone, L ;
Hudziak, H ;
Rhin, B ;
Delanoe, C ;
LeFaou, A ;
Bigard, MA ;
Gaucher, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (04) :237-240
[6]   Digestive endoscopy is not a major risk factor for transmitting hepatitis C virus [J].
Ciancio, A ;
Manzini, P ;
Castagno, F ;
D'Antico, S ;
Reynaudo, P ;
Coucourde, L ;
Ciccone, G ;
Del Piano, M ;
Ballarè, M ;
Peyre, S ;
Rizzi, R ;
Barletti, C ;
Bruno, M ;
Caronna, S ;
Carucci, P ;
Venon, WD ;
De Angelis, C ;
Morgando, A ;
Musso, A ;
Repici, A ;
Rizzetto, M ;
Saracco, G .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (11) :903-909
[7]   Review of injection drug use in six African countries:: Egypt, Kenya, Mauritius, Nigeria, South Africa and Tanzania [J].
Dewing, Sarah ;
Pluddemann, Andreas ;
Myers, Bronwyn J. ;
Parry, Charles D. H. .
DRUGS-EDUCATION PREVENTION AND POLICY, 2006, 13 (02) :121-137
[8]   Epidemiology of hepatitis C virus infection in Australia [J].
Dore, GJ ;
Law, M ;
MacDonald, M ;
Kaldor, JM .
JOURNAL OF CLINICAL VIROLOGY, 2003, 26 (02) :171-184
[9]  
El-Zanaty F, 2009, EGYPT DEMOGRAPHIC HL
[10]   The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt [J].
Frank, C ;
Mohamed, MK ;
Strickland, GT ;
Lavanchy, D ;
Arthur, RR ;
Magder, LS ;
El Khoby, T ;
Abdel-Wahab, Y ;
Ohn, EA ;
Anwar, W ;
Sallam, I .
LANCET, 2000, 355 (9207) :887-891